Combination of | |
---|---|
Hydrocodone | Opioid agonist |
Homatropine | Muscarinic antagonist |
Clinical data | |
Trade names | Tussigon, Hycodan, Hydromet, others |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
License data | |
Routes of administration | By mouth |
ATC code |
|
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
KEGG |
Hydrocodone/homatropine, sold under the brand name Tussigon among others, is a fixed-dose combination medication used for the treatment of cough.[1][2] It contains hydrocodone, as the bitartrate, an opioid agonist; and homatropine, as the methylbromide, a muscarinic antagonist.[1][2] It is taken by mouth.[1][2]
Hydrocodone/homatropine was approved for medical use in the United States in 1943.[1][2]
Adverse effects
In the US, the label for hydrocodone/homatropine contains a black box warning about addiction, abuse, and misuse.[1][2]
References
- 1 2 3 4 5 6 "Hycodan- hydrocodone bitartrate and homatropine methylbromide tablet; Hycodan- hydrocodone bitartrate and homatropine methylbromide solution". DailyMed. 29 December 2021. Retrieved 23 December 2023.
- 1 2 3 4 5 6 "Hydromet- hydrocodone bitartrate and homatropine methylbromide solution". DailyMed. 30 September 2022. Retrieved 23 December 2023.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.